Table 3 Bivariate logistic regression model with odds of use of BB-CAM, adjusted for selected patients´ characteristics
| CHARACTERISTICS | BB-CAM USE | ||||
|---|---|---|---|---|---|
| Odds ratio | 95% CI | p | |||
| Lower | Upper | ||||
| Age (years) | |||||
| ≤60 yrs. | 1.00 (Reference) | ||||
| >60 yrs. | .612 | .385 | .972 | .038 | |
| Therapy | |||||
| Bisphosphonates | No medication | 1.00 (Reference) | |||
| Medication | .975 | .532 | 1.787 | .934 | |
| Antibodies | No medication | 1.00 (Reference) | |||
| Medication | .875 | .503 | 1.521 | .635 | |
| Endocrine | No medication | 1.00 (Reference) | |||
| Medication | 1.018 | .547 | 1.895 | .955 | |
| Chemotherapy | No medication | 1.00 (Reference) | |||
| Medication | 1.576 | .879 | 2.824 | .126 | |
| Therapy line | .390 | ||||
| Breast-Ca | Neoadjuvant | 1.00 (Reference) | |||
| Adjuvant | .766 | .316 | 1.857 | ||
|
Metastasis 1st -line | .394 | .159 | .973 | ||
|
Metastasis 2nd -line | .823 | .302 | 2.242 | ||
|
Metastasis 3rd -line | 1.649 | .384 | 7.073 | ||
|
Metastasis ≥4th -line | .948 | .355 | 2.530 | ||
|
Recurrence 1st -line | .892 | .149 | 5.320 | ||
|
Recurrence ≥2nd -line | .372 | .054 | 2.544 | ||
| Ovarian-Ca | Adjuvant | 1.072 | .371 | 3.099 | |
| Recurrent | 1.035 | .363 | 2.955 | ||